DENALI ADVISORS LLC - ISIS PHARMACEUTICALS INC ownership

ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 357 filers reported holding ISIS PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 1.83 and the average weighting 0.2%.

Quarter-by-quarter ownership
DENALI ADVISORS LLC ownership history of ISIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2015$866,00013,6000.20%
Other shareholders

There were no reported owners of ISIS PHARMACEUTICALS INC in Q2 2015.

NameSharesValueWeighting ↓
View complete list of ISIS PHARMACEUTICALS INC shareholders